NAUT · Categories · Form 4

NAUT - SEC Form 4 insider transactions

Nautilus Biotechnology Inc. (NAUT) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for NAUT

• 64d
  SEC Form 4 filed by Director Posard Matthew L.

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 64d
  SEC Form 4 filed by Director Akinsanya Karen

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 64d
  SEC Form 4 filed by Director Nazem Farzad

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 64d
  SEC Form 4 filed by Director Mcilwain Matthew S

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 64d
  SEC Form 4 filed by Director Epperly Melissa B,

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 82d
  Large owner Ah Equity Partners Bio Ii, L.L.C. sold $11,750,000 worth of shares (5,000,000 units at $2.35) (SEC Form 4)

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 174d
  SEC Form 4 filed by CFO and Treasurer Mowry Anna

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 174d
  SEC Form 4 filed by Chief Scientist Mallick Parag

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 174d
  SEC Form 4 filed by CEO, President, and Secretary Patel Sujal M

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 174d
  SEC Form 4 filed by Chief People Officer Weld Gwen E

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 174d
  SEC Form 4 filed by Senior VP, Product Development Sankar Subramanian

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 174d
  SEC Form 4 filed by General Counsel Murphy Matthew B.

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 174d
  SEC Form 4 filed by Chief Marketing Officer Suzuki Kentaro

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 426d
  SEC Form 4 filed by Director Epperly Melissa B,

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 426d
  SEC Form 4 filed by Director Posard Matthew L.

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 426d
  SEC Form 4 filed by Director Mcilwain Matthew S

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 426d
  SEC Form 4 filed by Director Nazem Farzad

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 426d
  SEC Form 4 filed by Director Akinsanya Karen

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 539d
  SEC Form 4 filed by General Counsel Murphy Matthew B.

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 539d
  SEC Form 4 filed by CFO and Treasurer Mowry Anna

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 539d
  SEC Form 4 filed by CBO & Senior VP, Bus. Dev. Nelson Nicholas A.

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 539d
  SEC Form 4 filed by Chief People Officer Weld Gwen E

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 539d
  SEC Form 4 filed by Chief Marketing Officer Suzuki Kentaro

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 539d
  SEC Form 4 filed by Chief Scientist Mallick Parag

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 539d
  SEC Form 4 filed by CEO, President, and Secretary Patel Sujal M

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 539d
  SEC Form 4 filed by Senior VP, Product Development Sankar Subramanian

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 699d
  Senior VP, Operations Godwin Mary E. exercised 47,031 shares at a strike of $0.46 and sold $134,744 worth of shares (47,031 units at $2.87) (SEC Form 4)

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 706d
  Senior VP, Operations Godwin Mary E. exercised 35,000 shares at a strike of $0.46 and sold $99,869 worth of shares (35,000 units at $2.85) (SEC Form 4)

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 707d
  SEC Form 4 filed by Chief Marketing Officer Suzuki Kentaro

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 799d
  SEC Form 4 filed by Director Mcilwain Matthew S

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 799d
  SEC Form 4 filed by Director Altman Michael Seth

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 799d
  SEC Form 4 filed by Director Perceptive Advisors Llc

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 799d
  SEC Form 4 filed by Director Akinsanya Karen

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 799d
  SEC Form 4 filed by Director Epperly Melissa B,

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 799d
  SEC Form 4 filed by Director Pande Vijay Satyanand

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 799d
  SEC Form 4 filed by Director Nazem Farzad

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 799d
  SEC Form 4 filed by Director Posard Matthew L.

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 903d
  SEC Form 4 filed by Patel Sujal M

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 903d
  SEC Form 4 filed by Nelson Nicholas A.

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 903d
  SEC Form 4 filed by Mallick Parag

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 903d
  SEC Form 4 filed by Mowry Anna

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 903d
  SEC Form 4 filed by Weld Gwen E

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 903d
  SEC Form 4 filed by Sankar Subramanian

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 903d
  SEC Form 4 filed by Godwin Mary E.

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 1162d
  SEC Form 4 filed by Perceptive Advisors Llc

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 1162d
  SEC Form 4 filed by Altman Michael Seth

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 1166d
  SEC Form 4 filed by Mcilwain Matthew S

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 1166d
  SEC Form 4 filed by Posard Matthew L.

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 1166d
  SEC Form 4 filed by Epperly Melissa B,

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 1166d
  SEC Form 4 filed by Pande Vijay Satyanand

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 1166d
  SEC Form 4 filed by Nazem Farzad

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 1166d
  SEC Form 4 filed by Akinsanya Karen

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 1273d
  SEC Form 4 filed by Patel Sujal M

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 1273d
  SEC Form 4 filed by Mowry Anna

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 1273d
  SEC Form 4 filed by Murphy Matthew B.

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 1273d
  SEC Form 4 filed by Godwin Mary E.

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 1273d
  SEC Form 4 filed by Mallick Parag

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 1273d
  SEC Form 4 filed by Weld Gwen E

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 1273d
  SEC Form 4 filed by Nelson Nicholas A.

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
• 1273d
  SEC Form 4 filed by Sankar Subramanian

  4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)

Other NAUT categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends